ANDRES
PALACIOS PICOS
Investigador en el periodo 1996-2023
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (6)
2011
-
Risk, Predictors, and Clinical Characteristics of Lymphoma Development in Primary Sjögren's Syndrome
Seminars in Arthritis and Rheumatism, Vol. 41, Núm. 3, pp. 415-423
2009
-
Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab
Journal of Hepatology, Vol. 51, Núm. 6, pp. 1091-1096
2008
-
A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia
Current Medical Research and Opinion, Vol. 24, Núm. 10, pp. 2931-2942
-
GEMOX-R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large-cell lymphoma: A phase II study
European Journal of Haematology, Vol. 80, Núm. 2, pp. 127-132
2007
-
Rituximab, gemcitabine and oxaliplatin: An effective regimen in patients with refractory and relapsing mantle cell lymphoma
Leukemia and Lymphoma, Vol. 48, Núm. 11, pp. 2172-2178
2005
-
Assessment of the markers of platelet and coagulation activation following transcatheter closure of atrial septal defects
International Journal of Cardiology, Vol. 98, Núm. 1, pp. 107-112